Table 1.
Demographic and clinical baseline characteristics of patients
| Parameters | Octreotide group (n=58) | Placebo group (n=58) | P** |
|---|---|---|---|
| Age | 54.63±1.85 | 55.72±1.59 | 0.34 |
| Gender (male/female) | 38/20 | 38/20 | >0.5 |
| Hb at admission (g/dL) | 10.99±3.49 | 11.04±3.1 | 0.5 |
| Systolic BP (mmHg) | 114.08±14.54 | 112.65±13.28 | 0.13 |
| Alcohol abuse, n (%) | 2 (3.4) | 4 (6.9) | 0.34 |
| Smocking, n (%) | 8 (13.8) | 14 (24.1) | 0.11 |
| NSAID, n (%) | 23 (39.65) | 15 (25.86) | >0.5 |
| Aspirin, n (%) | 20 (34.48) | 19 (32.75) | >0.5 |
| Helicobacter pylori (Pathology positive), n (%) | 32 (55.17) | 39 (62.24) | 0.12 |
| Reason of GI bleeding | 0.98 | ||
| GU | 21 (36.2) | 20 (34.5) | |
| DU | 26 (44.8) | 27 (46.6) | |
| Esophagitis | 4 (6.9) | 4 (6.9) | |
| MWT | 4 (6.9) | 3 (5.2) | |
| EG/ED | 5 (8.6) | 2 (3.4) | |
| Classification of patients based on Rockall, Blatchford, and AIMS65 scores | |||
| Rockall score | 0.12 | ||
| ≤2 | 25 (43.1) | 38 (65.51) | |
| 3-7 | 32 (55.17) | 20 (34.48) | |
| ≥8 | 1 (1.72) | 0 | |
| Blatchford score | 0.61 | ||
| 0 | 9 (15.51) | 6 (10.34) | |
| 1-5 | 15 (25.86) | 21 (36.20) | |
| ≥6 | 33 (56.89) | 31 (53.44) | |
| AIMS65 score | 0.75 | ||
| ≤2 | 58 (100) | 56 (96.55) | |
| >2 | 0 | 2 (3.44) |
**Spearman’s statistical test. Hb=Hemoglobin, BP=Blood pressure, NSAID=Nonsteroidal anti-inflammatory drug, MWT=Mallory-Weiss tear, EG/ED=Erosive gastritis/Erosive doudenitis, GI=Gastrointestinal, GU=Gastric ulcer, DU=Duodenal ulcer